Company profile
Medtronic plc
NYSE: MDT · Healthcare · Medical - Devices
PublicHQ Galway, CIK 0001613103Reports USD
#20 of 1,422 Healthcare companies by revenue54th-percentile growth
EA Score
85AFH 85DQ 89GM 67SS 99
v0.1 · 65/100 weight · provisional
↑ listing tenure, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$36.4B
Rev growth YoY (TTM)
+8.4%
Net income (FY)
$4.8B
Employees
95,000
as of 2026-08-04
Market cap
$111.0B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$36.4B$36.4B2026
Net income$4.8B$4.8B2026
Operating income$6.5B$6.5B2026
Total assets$93.0B$93.0B2026
Liabilities$43.0B$43.0B2026
Equity$49.5B$49.5B2026
Revenue trend
FY2020 – FY2026 · USD
FY20
FY20
FY21
FY22
FY23
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
Cardiac and Vascular Group39%
Neuroscience Group28%
Medical Surgical24%
Diabetes Group9%
By geography
UNITED STATES80%
Total Other Countries, Excluding United States and Ireland20%
IRELAND0%
The read
What is Medtronic plc’s revenue?
Medtronic plc booked $36.4B in FY2026 revenue, growing 8.4% year over year — about the middle of the pack among Healthcare companies we track, at a 13.2% net margin.
Peers · Healthcare
Thermo Fisher Scientific Inc.86AAbbott Laboratories87AAmgen Inc.88AGilead Sciences, Inc.87AMedline Inc.62CStryker Corporation87AKey facts
CEOGeoffrey Straub Martha
SectorHealthcare
IndustryMedical - Devices
HeadquartersGalway, null
ExchangeNYSE: MDT
Employees95,000
IPO date1973-05-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.